Reversing the Effects of 0.5% Bupivacaine

NCT02995291 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia, Local

Interventions

DRUG: OraVerse
DRUG: Saline Water (Control)

Sponsor

Dalhousie University